PDF herunterladen
Horm Metab Res 2024; 56(08): 574-584
DOI: 10.1055/a-2238-1710
Original Article: Endocrine Care

Maternal Gestational Diabetes Mellitus and Congenital Heart Disease in Offspring: A Meta-Analysis

Yun Liu‡
1   Obstetrical Department, Xiangyang Central Hospital, Xiangyang City, China
,
Lina Yue‡
2   Department of Pediatrics, Xiangyang Maternal and Child Health Hospital, Xiangyang City, China
,
Li Chang
2   Department of Pediatrics, Xiangyang Maternal and Child Health Hospital, Xiangyang City, China
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Maternal diabetes has been related to an increased risk of congenital heart disease (CHD) in offspring. However, inconsistent results were retrieved for studies evaluating the association between gestational diabetes mellitus (GDM) and CHD in offspring. We therefore performed a systematic review and meta-analysis for comprehensive investigation. Observational studies were identified by searching PubMed, Embase, and Web of Science according to the aim of the meta-analysis. A randomized-effects model was used to pool the data by incorporating the influence of potential heterogeneity. Twenty-three observational studies, involving 46953078 mother-child pairs, were available for the meta-analysis. Among them, 2131800 mothers were diagnosed as GDM and 214379 newborns had CHD. Overall, maternal GDM was associated with a higher incidence of CHD in offspring [odds ratio (OR): 1.32, 95% confidence interval (CI): 1.21 to 1.45, p<0.001; I2=62%]. Sensitivity analysis limited to studies with adjustment of maternal age and other potential confounding factors showed similar results (OR: 1.40, 95% CI: 1.30 to 1.51, p<0.001; I2=47%). Subgroup analysis suggested that the association between maternal GDM and CHD in offspring was not significantly affected by methods for diagnosis of GDM, methods for confirmation of CHD, or study quality scores (p for subgroup difference all>0.05). Subsequent analysis according to types of CHD showed that maternal GDM was associated with higher risks of atrial septal defect, ventricular septal defect, and Tetralogy of Fallot. Maternal GDM may be associated with a higher risk of CHD in offspring.

Key words

gestational diabetes mellitus - congenital heart disease - offspring - risk factor - meta-analysis


Publikationsverlauf

Eingereicht: 05. Oktober 2023

Angenommen nach Revision: 15. Dezember 2023

Artikel online veröffentlicht:
02. Februar 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Zhang Y, Wang J, Zhao J. et al. Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China. Lancet Child Adolesc Health 2023; 7: 479-489
    CrossrefPubMedGoogle Scholar
  • 2 Giang KW, Mandalenakis Z, Fedchenko M. et al. Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden. Eur J Prev Cardiol 2023; 30: 169-176
    CrossrefPubMedGoogle Scholar
  • 3 Liu Y, Chen S, Zuhlke L. et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019; 48: 455-463
    CrossrefPubMedGoogle Scholar
  • 4 [Anonymous] Global, regional, and national burden of congenital heart disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child Adolesc Health 2020; 4: 185-200
    CrossrefPubMedGoogle Scholar
  • 5 Ma K, He Q, Dou Z. et al. Current treatment outcomes of congenital heart disease and future perspectives. Lancet Child Adolesc Health 2023; 7: 490-501
    CrossrefPubMedGoogle Scholar
  • 6 Sun R, Liu M, Lu L. et al. Congenital heart disease: causes, diagnosis, symptoms, and treatments. Cell Biochem Biophys 2015; 72: 857-860
    CrossrefPubMedGoogle Scholar
  • 7 Nie X, Liu X, Wang C. et al. Assessment of evidence on reported non-genetic risk factors of congenital heart defects: the updated umbrella review. BMC Pregnancy Childbirth 2022; 22: 371
    CrossrefPubMedGoogle Scholar
  • 8 Mires S, Reddy S, Skerritt C. et al. Maternal metabolomic profiling and congenital heart disease risk in offspring: a systematic review of observational studies. Prenat Diagn 2023; 43: 647-660
    CrossrefPubMedGoogle Scholar
  • 9 Wu L, Li N, Liu Y. Association between maternal factors and risk of congenital heart disease in offspring: a systematic review and meta-analysis. Matern Child Health J 2023; 27: 29-48
    CrossrefPubMedGoogle Scholar
  • 10 Chen ZY, Mao SF, Guo LH. et al. Effect of maternal pregestational diabetes mellitus on congenital heart diseases. World J Pediatr 2023; 19: 303-314
    CrossrefPubMedGoogle Scholar
  • 11 Maduro C, Castro LF, Moleiro ML. et al. Pregestational diabetes and congenital heart defects. Rev Bras Ginecol Obstet 2022; 44: 953-961
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 12 Papazoglou AS, Moysidis DV, Panagopoulos P. et al. Maternal diabetes mellitus and its impact on the risk of delivering a child with congenital heart disease: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2022; 35: 7685-7694
    CrossrefPubMedGoogle Scholar
  • 13 Chen L, Yang T, Wang L. et al. Risk of congenital heart defects in offspring exposed to maternal diabetes mellitus: an updated systematic review and meta-analysis. Arch Gynecol Obstet 2019; 300: 1491-1506
    CrossrefPubMedGoogle Scholar
  • 14 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
    CrossrefPubMedGoogle Scholar
  • 15 Page MJ, Moher D, Bossuyt PM. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021; 372: n160
    CrossrefPubMedGoogle Scholar
  • 16 Higgins J, Thomas J, Chandler J. et al. Cochrane handbook for systematic reviews of interventions version 6.2. The Cochrane Collaboration. 2021 www.training.cochrane.org/handbook
    PubMedGoogle Scholar
  • 17 Wells GA, Shea B, O'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
    PubMedGoogle Scholar
  • 18 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
    CrossrefPubMedGoogle Scholar
  • 19 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
    CrossrefPubMedGoogle Scholar
  • 20 Janssen PA, Rothman I, Schwartz SM. Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. Paediatr Perinat Epidemiol 1996; 10: 52-63
    CrossrefPubMedGoogle Scholar
  • 21 Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001; 61: 85-95
    CrossrefPubMedGoogle Scholar
  • 22 Sheffield JS, Butler-Koster EL, Casey BM. et al. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002; 100: 925-930
    PubMedGoogle Scholar
  • 23 Sharpe PB, Chan A, Haan EA. et al. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. Birth Defects Res A Clin Mol Teratol 2005; 73: 605-611
    CrossrefPubMedGoogle Scholar
  • 24 Peticca P, Keely EJ, Walker MC. et al. Pregnancy outcomes in diabetes subtypes: how do they compare? A province-based study of Ontario, 2005-2006. J Obstet Gynaecol Can 2009; 31: 487-496
    CrossrefPubMedGoogle Scholar
  • 25 Banhidy F, Acs N, Puho EH. et al. Congenital abnormalities in the offspring of pregnant women with type 1, type 2 and gestational diabetes mellitus: a population-based case-control study. Congenit Anom (Kyoto) 2010; 50: 115-121
    CrossrefPubMedGoogle Scholar
  • 26 Alverson CJ, Strickland MJ, Gilboa SM. et al. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 2011; 127: e647-e653
    CrossrefPubMedGoogle Scholar
  • 27 Mateja WA, Nelson DB, Kroelinger CD. et al. The association between maternal alcohol use and smoking in early pregnancy and congenital cardiac defects. J Womens Health (Larchmt) 2012; 21: 26-34
    CrossrefPubMedGoogle Scholar
  • 28 Liu X, Liu G, Wang P. et al. Prevalence of congenital heart disease and its related risk indicators among 90,796 Chinese infants aged less than 6 months in Tianjin. Int J Epidemiol 2015; 44: 884-893
    CrossrefPubMedGoogle Scholar
  • 29 Leirgul E, Brodwall K, Greve G. et al. Maternal diabetes, birth weight, and neonatal risk of congenital heart defects in Norway, 1994-2009. Obstet Gynecol 2016; 128: 1116-1125
    CrossrefPubMedGoogle Scholar
  • 30 Oyen N, Diaz LJ, Leirgul E. et al. Prepregnancy diabetes and offspring risk of congenital heart disease: a nationwide cohort study. Circulation 2016; 133: 2243-2253
    CrossrefPubMedGoogle Scholar
  • 31 Billionnet C, Mitanchez D, Weill A. et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 2017; 60: 636-644
    CrossrefPubMedGoogle Scholar
  • 32 Hoang TT, Marengo LK, Mitchell LE. et al. Original findings and updated meta-analysis for the association between maternal diabetes and risk for congenital heart disease phenotypes. Am J Epidemiol 2017; 186: 118-128
    CrossrefPubMedGoogle Scholar
  • 33 Yang GR, Dye TD, Li D. Effects of pre-gestational diabetes mellitus and gestational diabetes mellitus on macrosomia and birth defects in Upstate New York. Diabetes Res Clin Pract 2019; 155: 107811
    CrossrefPubMedGoogle Scholar
  • 34 Dolk H, McCullough N, Callaghan S. et al. Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study. PLoS One 2020; 15: e0227908
    CrossrefPubMedGoogle Scholar
  • 35 Wu Y, Liu B, Sun Y. et al. Association of maternal prepregnancy diabetes and gestational diabetes mellitus with congenital anomalies of the newborn. Diabetes Care 2020; 43: 2983-2990
    CrossrefPubMedGoogle Scholar
  • 36 Zhao M, Diao J, Huang P. et al. Association of maternal diabetes mellitus and polymorphisms of the NKX2.5 gene in children with congenital heart Disease: a single centre-based case-control study. J Diabetes Res 2020; 3854630
    PubMedGoogle Scholar
  • 37 Alyousif SMM, Aldokhel FT, Alkhanbashi OK. et al. The incidence of congenital heart defects in offspring among women with diabetes in Saudi Arabia. Cureus 2021; 13: e14225
    PubMedGoogle Scholar
  • 38 Schraw JM, Langlois PH, Lupo PJ. Comprehensive assessment of the associations between maternal diabetes and structural birth defects in offspring: a phenome-wide association study. Ann Epidemiol 2021; 53: 14-20 e18
    CrossrefPubMedGoogle Scholar
  • 39 Tinker SC, Gilboa SM, Moore CA. et al. Modification of the association between diabetes and birth defects by obesity, National Birth Defects Prevention Study, 1997-2011. Birth Defects Res 2021; 113: 1084-1097
    CrossrefPubMedGoogle Scholar
  • 40 Wu XX, Ge RX, Huang L. et al. Pregestational diabetes mediates the association between maternal obesity and the risk of congenital heart defects. J Diabetes Investig 2022; 13: 367-374
    CrossrefPubMedGoogle Scholar
  • 41 He R, Hornberger LK, Kaur A. et al Risk of major congenital heart disease in maternal diabetes is modified by hemoglobin A1c. Ultrasound Obstet Gynecol 2023; DOI: 10.1002/uog.27456. Online ahead of print
    CrossrefPubMedGoogle Scholar
  • 42 Portilla RE, Harizanov V, Sarmiento K. et al. Risk factors characterisation for CHD: a case-control study in Bogota and Cali, Colombia, 2002-2020. Cardiol Young 2023; DOI: 10.1017/S1047951123001324.
    CrossrefPubMedGoogle Scholar
  • 43 Huynh J, Yamada J, Beauharnais C. et al. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta 2015; 36: 1161-1166
    CrossrefPubMedGoogle Scholar
  • 44 Wicklow BA, Sellers EAC, Sharma AK. et al. Association of gestational diabetes and type 2 diabetes exposure in utero with the development of type 2 diabetes in first nations and non-first nations offspring. JAMA Pediatr 2018; 172: 724-731
    CrossrefPubMedGoogle Scholar
  • 45 Shefali AK, Kavitha M, Deepa R. et al. Pregnancy outcomes in pre-gestational and gestational diabetic women in comparison to non-diabetic women--A prospective study in Asian Indian mothers (CURES-35). J Assoc Physicians India 2006; 54: 613-618
    PubMedGoogle Scholar
  • 46 Fong A, Serra A, Herrero T. et al. Pre-gestational versus gestational diabetes: a population based study on clinical and demographic differences. J Diabetes Complicat 2014; 28: 29-34
    CrossrefPubMedGoogle Scholar
  • 47 Su D, Song JX, Gao Q. et al. Cited2 participates in cardiomyocyte apoptosis and maternal diabetes-induced congenital heart abnormality. Biochem Biophys Res Commun 2016; 479: 887-892
    CrossrefPubMedGoogle Scholar
  • 48 Mohammed OJ, Latif ML, Pratten MK. Diabetes-induced effects on cardiomyocytes in chick embryonic heart micromass and mouse embryonic D3 differentiated stem cells. Reprod Toxicol 2017; 69: 242-253
    CrossrefPubMedGoogle Scholar
  • 49 Turhan U, Yilmaz E, Gul M. et al. Investigation of the effect of gestational diabetes on fetal cardiac tissue in streptozotocin induced in rats. Acta Cir Bras 2018; 33: 306-313
    CrossrefPubMedGoogle Scholar
  • 50 Camarillo CO, Diaz-Rosas G, Avalos-Rodri Guez A. et al. Changes in miR 21 and 23b expression in postnatal hypertrophic heart derived from gestational diabetes precede dilated cardiomyopathy. J Biosci 2021; 46: 73
    CrossrefPubMedGoogle Scholar